Atlas Trials

A Study to Evaluate the Effects of Aflibercept on QTc Interval in Cancer Patients

Clinical trial NCT00876044 · COMPLETED

Trial details

NCT number
NCT00876044
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2009-04-01
Primary completion
2010-02-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.